14 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
that reasonably could be expected to give rise to a conflict of interest.
Transactions with Our Principal Shareholders, Directors and Members of our Senior
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case
8-K
EX-10.3
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
, committee charters, corporate governance, ethics, conflict of interest, confidentiality, share ownership and trading policies and guidelines and other … ) any proposed transaction between the Company and the Investor, or any of its respective Affiliates, or (iv) any actual or potential conflict
8-K
EX-10.2
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case
6-K
EX-99.1
77vwrjh72alcbs r6c
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-99.2
no5t737 jgwy
8 Nov 21
Securities Purchase Agreement
5:28pm
20-F
uhdz 6extqgxm766bvm4
23 Nov 18
Annual report (foreign)
12:00am
S-8
EX-4.1
ksnt3indnajy0
31 Jul 18
Registration of securities for employees
4:09pm
F-1/A
EX-3.1
tw0m 4gsufpwek944lhu
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
EX-3.1
a2tzvolv8
8 Jun 18
Registration statement (foreign) (amended)
6:25am
- Prev
- 1
- Next